Feedback plc (AIM: FDBK)
London
· Delayed Price · Currency is GBP · Price in GBX 19.95
+0.15 (0.76%)
Jan 21, 2025, 8:02 AM GMT+1
Feedback Revenue
In the fiscal year ending May 31, 2024, Feedback had annual revenue of 1.18M GBP with 15.27% growth. Feedback had revenue of 744.54K in the half year ending May 31, 2024, with 81.78% growth.
Revenue
1.18M
Revenue Growth
+15.27%
P/S Ratio
2.23
Revenue / Employee
43.76K
Employees
27
Market Cap
8.68M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2024 | 1.18M | 156.55K | 15.27% |
| May 31, 2023 | 1.02M | 436.42K | 74.15% |
| May 31, 2022 | 588.58K | 301.16K | 104.78% |
| May 31, 2021 | 287.42K | -162.57K | -36.13% |
| May 31, 2020 | 449.98K | -113.11K | -20.09% |
| May 31, 2019 | Pro | Pro | Pro |
| May 31, 2018 | Pro | Pro | Pro |
| May 31, 2017 | Pro | Pro | Pro |
| May 31, 2016 | Pro | Pro | Pro |
| May 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| GSK plc | 31.31B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| ConvaTec Group | 1.74B |
| Hikma Pharmaceuticals | 2.39B |
| HUTCHMED (China) | 483.31M |
| Oxford Nanopore Technologies | 167.75M |